Art. 82 Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…

In forcesince 28 Jan 2022cited 4×
1.

Only one authorisation may be granted to an applicant for a specific medicinal product.

However, the Commission shall authorise the same applicant to submit more than one application to the Agency for that medicinal product when there are objective verifiable reasons relating to public health regarding the availability of medicinal products to health-care professionals and/or patients, or for co-marketing reasons.

2.

As regards medicinal products for human use, Article 98(3) of Directive 2001/83/EC shall apply to medicinal products authorised under this Regulation.

3.

Without prejudice to the unique Union nature of the content of the documents referred to in points (a) to (d) of Article 9(4), this Regulation shall not prohibit the use of two or more commercial designs for a given medicinal product for human use covered by a single marketing authorisation.

  • Judgment of the General Court (Second Chamber) of 15 September 2015. Novartis Europharm Ltd v European Commission.Decision

    As confirmed by the intervener at the hearing, under the rules laid down by Regulation No 2309/93, there was nothing to prevent several separate marketing authorisations being granted in respect of a single medicinal product, restrictions …

    15 Sep 2015 · 62012TJ0472

  • Arrêt du Tribunal (deuxième chambre) du 15 septembre 2015. Novartis Europharm Ltd contre Commission européenne.Decision

    … Article 3(1) and (2), Article 4(1), Article 6(1), Article 14(11), Article 82(1), Article 89 and Article 90 of Regulation No 726/2004 are worded as follows: ‘Article 3 1. No medicinal product appearing in the Annex may be placed on the …

    15 Sep 2015 · 62013TJ0067

  • Regulation (EU) 2019/5Lawamends

  • Opinion of Advocate General Kokott delivered on 4 October 2018. Staat der Nederlanden v Warner-Lambert Company LLC.Decision

    With regard to multiple authorisations, Article 82(1) of Regulation No 726/2004 makes the following provision: ‘Only one authorisation may be granted to an applicant for a specific medicinal product. However, the Commission shall …

    4 Oct 2018 · 62017CC0423